Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Interest Coverage Ratio (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest Coverage Ratio came in at 25.41 in Q2 2026, up 17.76% year-over-year from 21.58 in Q2 2025, and up 8.62% quarter-over-quarter from 23.39 in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 25.41 for Q2 2026.

  • In Q2 2026, Interest Coverage Ratio rose 17.76% year-over-year to 25.41; the TTM figure through Jun 2026 stood at 25.73 (up 0.95% YoY), while the FY2025 annual figure was 26.13, down 6.14% from the prior year.
  • Interest Coverage Ratio came in at 25.41 for Q2 2026 at Johnson & Johnson, up from 23.39 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 435.2 in Q2 2022 to a low of 21.58 in Q2 2025.
  • Average Interest Coverage Ratio over 5 years is 59.3, with a median of 27.56 recorded in 2023.
  • Year-over-year, Interest Coverage Ratio surged 315.73% in 2022 and slumped 93.8% in 2023.
  • Over 5 years, Interest Coverage Ratio stood at 103.9 in 2022, then tumbled by 72.9% to 28.15 in 2023, then dropped by 6.69% to 26.27 in 2024, then fell by 2.04% to 25.73 in 2025, then retreated by 1.26% to 25.41 in 2026.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 25.41 in Q2 2026, 23.39 in Q1 2026, and 25.73 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 25.41
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 10.28
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 3.65
7 Revolution Medicines 42.88 Bn 42.88 Bn - -21.24
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1,199.14
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 114.07
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 52.24
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 25.41
Mar 29, 2026 23.39
Dec 28, 2025 25.73
Sep 28, 2025 28.71
Jun 29, 2025 21.58
Mar 30, 2025 30.30
Dec 29, 2024 26.27
Sep 29, 2024 26.10
Jun 30, 2024 23.96
Mar 31, 2024 38.12
Dec 31, 2023 28.15
Oct 1, 2023 29.90
Jul 2, 2023 26.79
Apr 2, 2023 26.96
Jan 1, 2023 44.88
Oct 2, 2022 103.90
Jul 3, 2022 102.08
Apr 3, 2022 435.20
Oct 3, 2021 330.30
Jul 4, 2021 155.05